<DOC>
	<DOCNO>NCT02087540</DOCNO>
	<brief_summary>To identify efficacy safety Telmisartan/Rosuvastatin co-administration hyperlipidemia control hypertensive patient hyperlipidemia compare monotherapy .</brief_summary>
	<brief_title>Efficacy Safety Telmisartan/Rosuvastatin Co-administration Hypertensive Patients With Hyperlipidemia</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Signed Informed Consent Men woman &gt; 18 year age Subject one 3 condition classifed Cardiovascular Risk Factors , 10Year Risk , Blood Pressure , LDLC , Coronary Artery Disease Equivalent Female pregnant , breastfeeding , childbearing potential , unwilling practice adequate contraception throughout study , . Other exclusion apply</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>